دورية أكاديمية

LBA48 Pathologic response and exploratory analyses of neoadjuvant-adjuvant versus adjuvant pembrolizumab (PEM) for resectable stage IIIb-IV melanoma from SWOG S1801

التفاصيل البيبلوغرافية
العنوان: LBA48 Pathologic response and exploratory analyses of neoadjuvant-adjuvant versus adjuvant pembrolizumab (PEM) for resectable stage IIIb-IV melanoma from SWOG S1801
المؤلفون: Patel, S., Othus, M., Wright, P., Hyngstrom, J., Lao, C.D., Truong, T-G., Chandra, S., Kendra, K., Devoe, C., Hegde, A., Mangla, A., Lowe, M., Buchbinder, E., Kirkwood, J.M., Sharon, E., Korde, L., Moon, J., Sondak, V.K., Ribas, A., Prieto, V.
المصدر: In Annals of Oncology October 2023 34 Supplement 2:S1288-S1288
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2023.10.042